Regulatory affairs may be a relatively new profession that developed from the will of governments to shield public health by dominant the protection and effectualness of merchandise in areas together with prescription drugs, veterinary medicines, medical devices, pesticides, agrochemicals, cosmetics, and complementary medicines. The companies accountable for the invention, testing, manufacture, and promotion of that merchandise additionally need to create sure that they provide merchandise that square measure safe and make a worthy contribution to public health and welfare. OMICS Group International is one of the leading Open Access Publishers which is publishing 700+ peer-reviewed journals with the support of 50,000+ editorial board members as an editorial team and aimed to disseminate the scholarly knowledge to the scientific society. OMICS Group also organizing 3000+ International Scientific Conferences and events yearly all over the world with the support of 1000+ Scientific associations worldwide.
Opinion Article: Pharmaceutical Regulatory Affairs: Open Access
Opinion Article: Pharmaceutical Regulatory Affairs: Open Access
Commentary: Pharmaceutical Regulatory Affairs: Open Access
Commentary: Pharmaceutical Regulatory Affairs: Open Access
Review Article: Pharmaceutical Regulatory Affairs: Open Access
Review Article: Pharmaceutical Regulatory Affairs: Open Access
Scientific Tracks Abstracts: Pharmacoeconomics: Open Access
Scientific Tracks Abstracts: Pharmacoeconomics: Open Access
Posters & Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Posters & Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Posters & Accepted Abstracts: Journal of Bioanalysis & Biomedicine
Posters & Accepted Abstracts: Journal of Bioanalysis & Biomedicine
Keynote: Journal of Bioanalysis & Biomedicine
Keynote: Journal of Bioanalysis & Biomedicine
Pharmaceutical Regulatory Affairs: Open Access received 533 citations as per Google Scholar report